Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qualia Iron Version A is a dietary supplement tested for iron supplementation, formulated by Qualia Life Sciences. It is being studied in clinical trials for improving iron status in adults over a 56-day period. The precise active ingredients, mechanism of action, and formulation details have not been disclosed in available sources. The supplement is administered orally, with a regimen of one or two capsules daily, five days on with two days off per week. The trial measures changes in iron status biomarkers and evaluates safety, tolerability, and quality of life. The product is not described as a pharmaceutical drug, and the trial aims at healthy adults seeking to improve or maintain iron status[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qualia Iron Version A.